Hyperoside, a flavonoid compound, inhibits proliferation and stimulates osteogenic differentiation of human osteosarcoma cells.
Osteosarcoma, one of the most common malignant bone tumours, is generally considered a differentiation disease caused by genetic and epigenetic disruptions in the terminal differentiation of osteoblasts. Novel therapies based on the non-cytotoxic induction of cell differentiation-responsive pathways...
Main Authors: | Ning Zhang, Mei-Dan Ying, Yong-Ping Wu, Zhi-Hong Zhou, Zhao-Ming Ye, Hang Li, Ding-Sheng Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4077650?pdf=render |
Similar Items
-
Hyperoside ameliorates periodontitis in rats by promoting osteogenic differentiation of BMSCs via activation of the NF‐κB pathway
by: Tao Xu, et al.
Published: (2020-09-01) -
Osteosarcoma (Osteogenic sarcoma)
by: Picci Piero
Published: (2007-01-01) -
Antioxidant Activity Evaluation of Dietary Flavonoid Hyperoside Using <i>Saccharomyces Cerevisiae</i> as a Model
by: Yuting Gao, et al.
Published: (2019-02-01) -
Interaction of Hyperoside with Human Serum Albumin and Effect of Glucose on the Binding
by: Jie Yang, et al.
Published: (2014-01-01) -
The Calcium-Binding Protein S100A6 Accelerates Human Osteosarcoma Growth by Promoting Cell Proliferation and Inhibiting Osteogenic Differentiation
by: Yasha Li, et al.
Published: (2015-12-01)